Related Experiment Video
Updated: Dec 25, 2025

07:50
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
771
Single-cell sequencing and its application in breast cancer
1Joint Laboratory for Translational Medicine Research, Liaocheng City People's Hospital, Liaocheng 252000, China.
Yi Chuan = Hereditas
|March 29, 2020
Summary
Single-cell sequencing reveals breast cancer complexity, detailing tumor cell interactions and microenvironments. This approach aids in personalized therapies and discovering new immunotherapy targets.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Breast cancer progression involves genetic alterations and heterogeneity, often missed by traditional sequencing.
- Intratumoral, intertumoral, and interpatient heterogeneity are critical factors in breast cancer development and treatment response.
- Understanding the tumor microenvironment and cell-cell interactions is crucial for effective cancer therapy.
Purpose of the Study:
- To review single-cell sequencing technologies and their applications in breast cancer research.
- To elucidate the complex interactions between breast cancer cells and their microenvironment at a single-cell level.
- To provide a foundation for improved understanding of breast cancer pathogenesis and novel immunotherapeutic strategies.
Main Methods:
- Review of state-of-the-art single-cell sequencing technologies.
- Analysis of transcriptomic data, including gene copy number and expression.
- Exploration of cellular composition, differentiation, and tumor microenvironment mapping.
Main Results:
- Single-cell sequencing effectively characterizes genomic alterations and subclone evolution.
- Detailed analysis of tumor microenvironment and immune cell interactions (T cells, macrophages).
- Identification of potential new therapeutic targets and immune checkpoints.
Conclusions:
- Single-cell sequencing offers a powerful tool for deciphering breast cancer heterogeneity and complexity.
- This technology supports accurate patient stratification and the development of personalized therapies.
- Understanding tumor-immune cell crosstalk at the single-cell level opens new avenues for breast cancer immunotherapy.

